Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea

被引:28
作者
Yoo, JH
Huh, DH
Choi, JH
Shin, WS
Kang, MW
Kim, CC
Kim, DJ
机构
[1] St Marys Hosp, Bone Marrow Transplantat Ctr, Dept Internal Med, Seoul 150010, South Korea
[2] St Marys Hosp, Clin Res Inst, Seoul, South Korea
[3] Catholic Univ, Coll Med, St Marys Hosp, Seoul, South Korea
关键词
D O I
10.1086/516132
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed an outbreak of Escherichia coli bacteremia in eight patients with leukemia in a hematology-oncology unit from July to September 1994, The antibiograms and genotypic patterns of the isolates were different, thus suggesting that the outbreak did not originate from a single clone. However, all the isolates were resistant to quinolones, which led us to examine the microbiological records from 1992 to 1994, The incidence of quinolone-resistant E, coli bacteremia in the hematology-oncology unit ranged from 81.8% to 94.6% during this period, We then analyzed 36 more isolates recovered from late 1994 to 1995. Field inversion gel electrophoresis patterns of these isolates were also different. Analysis of the quinolone resistance determining region in gyrA revealed that all the isolates had a double mutation in gyrA. In conclusion, quinolone-resistant E. coli could be an emerging threat to neutropenic patients with leukemia who receive a quinolone prophylactically, and attention must be paid to this trend of resistance.
引用
收藏
页码:1385 / 1391
页数:7
相关论文
共 15 条
[1]  
Ausubel FM, 1995, SHORT PROTOCOLS MOL
[2]  
BIRREN B, 1993, PULSED FIELD GEL ELE, P107
[3]   Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis [J].
Carratala, J ;
FernandezSevilla, A ;
Dominguez, FTMA ;
Gudiol, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :503-505
[4]   ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES IN PATIENTS WITH CANCER AND NEUTROPENIA [J].
COMETTA, A ;
CALANDRA, T ;
BILLE, J ;
GLAUSER, MP .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1240-1241
[5]  
DARNBUSCH K, 1990, J ANTIMICROB CHEMOTH, V26, P269
[6]   CHARACTERIZATION OF FLUORO QUINOLONE-RESISTANT MUTANTS OF ESCHERICHIA-COLI SELECTED IN-VITRO [J].
HEISIG, P ;
TSCHORNY, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1284-1291
[7]   NEW TOPOISOMERASE ESSENTIAL FOR CHROMOSOME SEGREGATION IN ESCHERICHIA-COLI [J].
KATO, J ;
NISHIMURA, Y ;
IMAMURA, R ;
NIKI, H ;
HIRAGA, S ;
SUZUKI, H .
CELL, 1990, 63 (02) :393-404
[8]   SELECTIVE DECONTAMINATION IN NEUTROPENIC PATIENTS [J].
KURRLE, E ;
SCHMEISER, T ;
KERN, W .
EPIDEMIOLOGY AND INFECTION, 1992, 109 (03) :327-335
[9]  
National Committee for Clinical Laboratory Standards, 1990, M2A4 NCCLS
[10]   Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers [J].
Oethinger, M ;
Conrad, S ;
Kaifel, K ;
Cometta, A ;
Bille, J ;
Klotz, G ;
Glauser, MP ;
Marre, R ;
Kern, WV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :387-392